NYSE:WST - West Pharmaceutical Services Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$104.45 -0.80 (-0.76 %)
(As of 01/22/2019 04:00 PM ET)
Previous Close$105.25
Today's Range$102.46 - $104.69
52-Week Range$82.74 - $125.09
Volume396,100 shs
Average Volume379,621 shs
Market Capitalization$7.74 billion
P/E Ratio37.27
Dividend Yield0.58%
Beta1.21
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.60 billion
Cash Flow$4.1074 per share
Book Value$17.24 per share

Profitability

Net Income$150.70 million

Miscellaneous

Employees7,500
Market Cap$7.74 billion
OptionableOptionable

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Wednesday, December 19th. Stockholders of record on Wednesday, January 23rd will be paid a dividend of $0.15 per share on Wednesday, February 6th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Tuesday, January 22nd. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services announced that its Board of Directors has authorized a share repurchase program on Thursday, February 15th 2018, which allows the company to buyback 800,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company's management believes its stock is undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) released its quarterly earnings results on Thursday, October, 25th. The medical instruments supplier reported $0.76 earnings per share for the quarter, topping analysts' consensus estimates of $0.70 by $0.06. The medical instruments supplier earned $431.70 million during the quarter, compared to analysts' expectations of $427.55 million. West Pharmaceutical Services had a return on equity of 15.78% and a net margin of 9.06%. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, February 21st 2019. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2018 earnings guidance on Thursday, October, 25th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.82. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion.

What price target have analysts set for WST?

2 brokers have issued 1 year price objectives for West Pharmaceutical Services' shares. Their forecasts range from $85.00 to $110.00. On average, they expect West Pharmaceutical Services' share price to reach $97.50 in the next year. This suggests that the stock has a possible downside of 6.7%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

News headlines about WST stock have trended very positive on Tuesday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. West Pharmaceutical Services earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are some of West Pharmaceutical Services' key competitors?

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 54)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (0.84%), Retirement Systems of Alabama (0.13%), McCollum Christoferson Group LLC (0.10%), Kistler Tiffany Companies LLC (0.07%), Louisiana State Employees Retirement System (0.03%) and State of Alaska Department of Revenue (0.01%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Riverbridge Partners LLC, Kistler Tiffany Companies LLC and Louisiana State Employees Retirement System. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone, Karen Flynn and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Fox Run Management L.L.C., Virtu Financial LLC, Contravisory Investment Management Inc., Oakbrook Investments LLC, McCollum Christoferson Group LLC, First Hawaiian Bank and State of Alaska Department of Revenue. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $104.45.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $7.74 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  173 (Vote Outperform)
Underperform Votes:  292 (Vote Underperform)
Total Votes:  465
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel